Calyx Bio-Ventures (CYX.V) up 20% on no news, CEO staying mum on details

Had a quick call with Calyx Bio-Ventures (CYX.V) CEO Roger Forde this morning, asking why his stock is starting to lift again.

He’s not talking.

He does say some of his staffers have cashed in options, and says they’re working hard on their ‘big code project’ that applies to the weed space, and I know from others close to the deal that CYX has taken out a large office space in downtown Vancouver to hold their new server stack and new hires, mostly techies, but I have no detail beyond that.

Forde says he’ll have me up to the space in the next few weeks but “can’t say anything at the moment for a variety of reasons.”

He’ll want to voice those reasons soon. The last CYX financing comes free-trading soon, so time will be of the essence if the company wants to encourage investors (myself included) to hold that paper. I’d expect (read: hope for) real news soon.

— Chris Parry

FULL DISCLOSURE: Calyx Bio-Ventures is an Equity.Guru client and the author holds stock in the company.

 

Leave a Reply

Be the First to Comment!

Notify of
avatar
wpDiscuz